Unicycive Therapeutics’ $25 Million IPO

Martina Bellini North America, North America Legal Chronicle
Tagged:

Schiff Hardin advised the underwriter on the deal.Unicycive Therapeutics (NASDAQ:UNCY) has priced its IPO of 5M units at $5.00/unit, for expected gross proceeds are $25M. Each…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here
  Share:
Martina Bellini

Author: Martina Bellini

…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here